What is NDC 67877-762?

67877-762 is the product NDC for Erythromycin, Erythromycin 250 mg/1 tablet, film coated, listed with the FDA by Ascend Laboratories, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.

Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Erythromycin?

68 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Erythromycin NDC 67877-762 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-762Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0762Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
67877-762-01	6787707620167877076201	100 TABLET, FILM COATED in 1 BOTTLE (67877-762-01)Marketed from Jul 14, 2022
67877-762-05	6787707620567877076205	500 TABLET, FILM COATED in 1 BOTTLE (67877-762-05)Marketed from Jul 14, 2022
67877-762-30	6787707623067877076230	30 TABLET, FILM COATED in 1 BOTTLE (67877-762-30)Marketed from Jul 14, 2022
67877-762-33	6787707623367877076233	1 BLISTER PACK in 1 CARTON (67877-762-33) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Jul 14, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Erythromycin
Generic name (nonproprietary): erythromycin
Active ingredients: Erythromycin — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Ascend Laboratories, LLCNDC labeler code 67877
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216066
Marketing start: Jul 14, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 67877-762_63d64de0-c590-4542-b3f3-92600d7dca18SPL ID 63d64de0-c590-4542-b3f3-92600d7dca18SPL set ID 3b415e31-e5d4-4990-8021-78459af73372RxCUI 197650, 598006UNII 63937KV33DUPC 0367877762012, 0367877762302, 0367877763019
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877076201 followed by a unit qualifier and the quantity

Package 67877-0762-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 17, 2025.

Indications (excerpt from the label)

INDICATIONS & USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets, USP and other antibacterial drugs, erythromycin tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Erythromycin tablets, USP are indicated in the treatment of infections caused by susceptible strains of the designated mi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67877-762

What is NDC 67877-762?: 67877-762 is the product NDC for Erythromycin, Erythromycin 250 mg/1 tablet, film coated, listed with the FDA by Ascend Laboratories, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Erythromycin.
What is the active ingredient?: Erythromycin.
Who is the labeler?: Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Erythromycin?: 68 other product NDCs are listed under this name. See all Erythromycin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Erythromycin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Sentiss Pharmaceuticals LLC	70244-031	70244-0031-0170244-0031-02
Erythromycin	Erythromycin 333 mg/1	Tablet, Delayed releaseOral	Torrent Pharmaceuticals Limited	13668-587	13668-0587-0113668-0587-0513668-0587-30
erythromycin	Erythromycin 250 mg/1	Capsule, Delayed release pelletsOral	Dr. Reddy's Labratories Inc.	75907-076	75907-0076-01
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	ST. MARY'S MEDICAL PARK PHARMACY	60760-670	60760-0670-35
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Redpharm Drug	67296-2128	67296-2128-03
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	NuCare Pharmaceuticals,Inc.	68071-3992	68071-3992-02
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	ARMAS PHARMACEUTICALS INC.	72485-670	72485-0670-3172485-0670-35
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Fera Pharmaceuticals, LLC	48102-057	48102-0057-11
Erythromycin	Erythromycin 250 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-397	46708-0397-3046708-0397-3146708-0397-91
Erythromycin	Erythromycin 500 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-398	46708-0398-3046708-0398-3146708-0398-91

All 69 Erythromycin NDCs

Other NDCs under ANDA 216066

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216066
Product	Strength	Form · route	Labeler	Product NDC
Erythromycin	Erythromycin 500 mg/1	Tablet, Film coatedOral	Ascend Laboratories, LLC	67877-763